Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.065 USD | +3.20% | +3.16% | -26.73% |
02/05 | CUREVAC : A missed opportunity | |
26/04 | UBS Cuts CureVac Price Target to $14 From $18, Maintains Buy Rating | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-26.73% | 665M | |
+29.81% | 48.16B | |
-1.01% | 41.73B | |
+43.45% | 41.03B | |
-5.26% | 28.77B | |
+10.10% | 25.59B | |
-22.97% | 18.96B | |
+8.27% | 12.92B | |
+28.90% | 12.03B | |
-1.86% | 11.77B |
- Stock Market
- Equities
- CVAC Stock
- News CureVac N.V.
- CUREVAC : UBS raises its recommendation to Buy